Icosabutate
Icosabutate is an orally active eicosapentaenoic acid derivative that inhibits hepatic inflammation and fibrosis, making it a candidate for NASH and liver fibrosis research. It also lowers triglycerides and improves cardiovascular risk profiles, supporting its study in atherosclerosis and residual hypertriglyceridemia.
Product Specifications
CAS Number
1253909-57-7
Product Name Alternative
Icosabutate, non-HDL-C, NST-4016, PRC-4016
Purity
97.50% (May vary between batches)
Solubility
DMSO:80 mg/mL (213.58 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (8.81 mM)
Smiles
CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCOC (CC) C (O) =O
Molecular Formula
C24H38O3
Molecular Weight
374.56
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
550487 200 µL
Tumor Necrosis Factor Receptor Superfamily, Member 14 (Biotin)
Sign In for Pricing
View Details 
MBS2126204-01 0.1 mL
PE-Linked Monoclonal Antibody to Complement Factor D (CFD)
Sign In for Pricing
View Details MBS2126204-02 0.2 mL
PE-Linked Monoclonal Antibody to Complement Factor D (CFD)
Sign In for Pricing
View Details MBS2126204-03 0.5 mL
PE-Linked Monoclonal Antibody to Complement Factor D (CFD)
Sign In for Pricing
View Details